Patient Issues

Health care policy decisions based on sound data and research are essential for addressing the challenges. Pharmacy Times Pharmacists are...

The Columbus Dispatch Millions of U.S. seniors were supposed to get price relief soon on their prescription drugs under a revamp of...

Patient and patient advocate Beth Waldron used her social media platform to criticize CVS Caremark’s removal of Eliquis (apixaban) from...

A.J. Loiacono was speaking at MedCity INVEST in late March in Chicago when an audience member requested him to address whether it is...

The Oklahoman When Oklahomans step up to my pharmacy counter, it’s usually because something is wrong. There is chronic disease, pain and...

Rebates should get focus in PBM probe, policy watchers say Proprietary data protections can complicate transparency Bloomberg Law The...

Misaligned incentives, spread pricing, opaque rebates, and specialty distribution models perpetuate extensive customer mistrust in PBMs,...

Indiana News Radio WIBC Last week a pharmaceutical industry expert named Antonio Ciaccia, testified in front of the Indiana General...

How insurers deflect criticism, avoid reform and preserve the status quo. Un-Covered When I was a health insurance communications exec, I...

No insurer has ever made that kind of money in U.S. history. Wendell Potter NOW Just days after a Commonwealth Fund report showed that...